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We report 1-year follow-up data from a longitudinal
prospective cohort study of patients with West Nile
virus–associated paralysis. As in the 4-month follow-up, a
variety of recovery patterns were observed, but persistent
weakness was frequent. Respiratory involvement was
associated with considerable illness and death.
D
uring the summer and fall of 2003, we conducted a
prospective, population-based study among residents
of Larimer, Weld, and Boulder Counties in northern
Colorado in whom West Nile virus (WNV)–associated
paralysis developed (1). We identified 32 patients with
paralysis and acute WNV infection. Clinical or neurodiag-
nostic findings suggested a poliomyelitis-like syndrome in
27 (84%) and a Guillain-Barré–like syndrome (GBLS) in
4 (13%); 1 patient had brachial plexus involvement alone.
The cohort was reevaluated 4 months later, at which time
3 patients with respiratory failure had died, 2 remained
intubated, 25 showed varying degrees of improvement,
and 2 were lost to follow-up. Here, we describe the results
of a 1-year follow-up evaluation of the 27 remaining
cohort members and describe the patterns of recovery, per-
sistence of symptoms and signs, and long-term outcome. 
The Study
By 1 year, 3 of the 27 remaining cohort members had
died (all with respiratory involvement), and an additional 2
persons (1 with poliomyelitis-like syndrome, 1 with
GBLS) were lost to follow-up, leaving 22 patients in the 1-
year cohort. Various degrees of strength improvement by
manual muscle testing (MMT) using the Medical Research
Council (MRC) 1–5 scale (2) were seen in the 18 of 27
patients with poliomyelitis-like syndrome at 1 year (online
Appendix Figure, available at http://www.cdc.gov/nci-
dod/EID/vol12no03/05-0643-G.htm). Greater gains in
MMT scores were seen between strength nadir and 4
months than between 4 months and 1 year by both subjec-
tive patient description and by serial MMT. Using a pro-
portional odds model (SUDAAN, version 9.0.1, Research
Triangle Institute, Research Triangle, NC, USA), we found
that MMT scores improved over the 3 evaluations
(p<0.001, adjusting for a significant MMT site effect),
with the odds ratio for 4 months (relative to the nadir) of
0.40 (95% confidence interval [CI] 0.25–0.63) and for 1
year of 0.23 (95% CI 0.14–0.36), supporting subjective
and objective assessment. Facial weakness, which had
been present in 10 patients, had completely resolved in all
patients by the 1-year follow-up.
One person (patient 27, Appendix Figure) who initially
had quadriplegia and respiratory involvement had returned
to pre-illness strength and had no detectable weakness on
MMT at 1-year follow-up. Four persons (3 with tetra- or
quadriplegia [patients 14, 15, and 31] and 1 with monople-
gia [patient 37]) had achieved near-baseline strength (trace
weakness on MMT) in affected limbs and reported little or
no functional difficulty. Between the 4-month and 1-year
follow-up, 4 persons (patients 3, 9, 16, 21) experienced
measurable continued improvement between 4 months and
1 year (improvement in MMT score in at least 1 affected
limb by >1 scale points), and 9 persons (patients 1, 7, 17,
20, 29, 34, 36, 41, 42) experienced little or no subsequent
improvement. Four patients (7, 17, 29, 37) had a 1-point
strength decrease in certain muscle groups and specific
ranges of motion on MMT between 4 months and 1 year;
however, overall strength for major joint ranges of motion
or the entire limb did not decrease. All patients employed
before illness onset (n = 11) had returned to work, 9 full-
time and 2 part-time. Two persons were still using ambu-
latory aids (canes); 2 others continued to use leg braces. 
Persistent symptoms and neurologic signs were
observed in 10 persons (Table). Dependent edema and skin
changes in affected limbs not present at 4 months were
observed in 6 patients. In 1 patient, a deep venous throm-
bosis of an affected monoplegic leg had developed, pre-
sumably because of lack of leg movement. Fatigue was the
most commonly reported subjective symptom (11, 56%),
followed by myalgias/body pains (6, 27%), anxiety and
depression (5, 23%), and mental/cognitive complaints and
muscle cramps (4, 18% each). 
One person with GBLS was lost to follow-up. Of the
remaining 3 patients, 2 (patients 10, 32) had returned to
baseline in terms of strength and overall functioning
(Appendix Figure). The patient with brachial plexopathy
and associated isolated shoulder abduction weakness had no
additional strength gains in affected muscle groups at 1 year
but continued to be unhampered functionally by this deficit.
By the 1-year follow-up, an additional 3 patients with
respiratory failure had died (at 4.5 months, 5 months, and
7 months, respectively, after symptom onset). Of the 6
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port in 5 and cardiac arrest in 1. No persons intubated for
>4 months survived. All 6 surviving patients had been dis-
charged from care facilities and were living at home. One
patient with GBLS and 1 with poliomyelitis-like syndrome
were lost to follow-up by 1 year. Four of the 6 survivors
required repeated episodes of extubation and reintubation
before being permanently extubated. Of the 4 patients
evaluated at 1 year, 2 still required assistance with all daily
activities and required supplemental oxygen. The other 2
patients experienced substantial improvements in strength
and functional ability, living independently and working at
1 year; however, both continued to experience persistent
parkinsonism, tremor, and fatigue. All patients with respi-
ratory involvement continued to experience orthopnea,
dyspnea on exertion, and weakness of cough.  
Of the 5 patients who experienced shortness of breath
and had diagnostic evidence of respiratory muscle dys-
function but did not require intubation, 2 required supple-
mental oxygen at some point during their recovery. At 1
year, 3 patients continued to experience substantial orthop-
nea and dyspnea on exertion, and 2 had no respiratory
symptoms. 
Conclusions
The 1-year follow-up findings among this cohort of
persons with WNV-associated paralysis demonstrate a
spectrum of functional and strength outcomes. Among sur-
vivors, all demonstrated at least some improvement in
strength of affected muscles, but improvement varied sub-
stantially. Consistent with findings at 4 months, those per-
sons with less profound initial weakness demonstrated the
greatest strength gains at 1 year. Strength gains among
patients were more substantial between the nadir and 4
months than in the following months, in which a plateau
was reached and less improvement was noted. The MRC
scale of MMT is not linear, and this slowing of improve-
ment may be attributable to the inherent nature of the
MMT scoring system. However, this pattern of improve-
ment is consistent with observations of recovery from
poliovirus infection, in which most strength gains occur
within 6 months (3). Persons with GBLS experienced
complete or near complete recovery, a commonly reported
outcome of this syndrome (4). Facial weakness was asso-
ciated with favorable prognosis; however, resolution of
weakness took >5 months in some cases. 
Respiratory involvement was associated with consider-
able death and illness; the death rate was 50%. With the
exception of 1 patient, death was due to a voluntary with-
drawal of ventilatory support. In 2 of these patients, cogni-
tion and awareness were intact at the time of support
withdrawal. Successful extubation among surviving
patients with respiratory involvement occurred only after
prolonged weaning periods (mean duration of intubation
66 days) (1) and often, multiple episodes of extubation and
reintubation. At the 1-year follow-up, 2 of the surviving
patients with respiratory involvement had severe disability
and required assistance with all activities. However, 2 oth-
ers with initial respiratory involvement did well; 1 experi-
enced complete strength recovery and the other
experienced recovery to the point of functional independ-
ence. Predictors of favorable outcome are unknown, but
the 2 persons with favorable outcome were relatively
young (45 and 43 years of age, respectively) and had no
preexisting medical conditions. In contrast, all but 1 person
who died or had a poor outcome were >56 years of age,
and 4 had noteworthy prior medical conditions. Only 1 of
the 5 patients with respiratory paralysis and quadriplegia
from poliomyelitis-like syndrome survived, but that
patient made a full and complete recovery; thus, respirato-
ry paralysis and quadriplegia do not appear to universally
indicate poor outcome. All persons recovering from respi-
ratory failure continued to describe mild persistent orthop-
nea and exertional dyspnea. Respiratory paralysis appears
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syndrome associated with substantial morbidity.
Although small decreases in strength of specific move-
ments at specific joints were noted in a few persons
between 4 months and 1 year (Appendix Figure), these
decreases were minor and observed in isolated ranges of
motion, and most likely reflected a combination of MMT
measurement variability, patient effort, and the method
used to calculate strength scores. Only 1 person displayed
worsening in strength of a major joint or limb after initial
improvement; a decrement in strength from the 4-month
time point was noted in the left upper arm of patient 15
because of limitation of testing of this limb from shoulder
arthritis pain. A relapse or subsequent worsening in
strength after an initial period of improvement was not
observed in these patients, although such phenomena have
been observed in patients with poliovirus infection (5).
The possibility of a “postpoliomyelitis syndrome” (6)
(e.g., development of weakness in a previously affected
limb years after recovery) is unknown and will require
longer term assessment.
Persistent associated neurologic signs and symptoms
were seen or reported in nearly all patients (Table).
Atrophy of affected limbs was common. Dependent
edema, presumably due to compartmental muscle weak-
ness and inability to augment blood circulation by muscu-
lar contraction, had been present to a mild degree in 2
persons at 4-month follow-up but was seen in 6 persons at
1 year. The development of a deep venous thrombosis in 1
person with leg paresis reinforces the need for vigilance
for this complication in persons with severe weakness and
lack of mobility. 
In summary, the longer-term outcome of WNV
poliomyelitis-like syndrome appears to be more heteroge-
neous than preliminary data may have suggested, with
some persons experiencing little neurologic and functional
improvement and others experiencing substantial gains.
The degree of initial weakness appears to be an indicator
of subsequent long-term outcome. WNV poliomyelitis-
like syndrome with respiratory involvement is a condition
associated with considerable death and illness; however,
substantial and even dramatic recovery is sometimes
observed in such patients. Persistent quadriplegia and res-
piratory failure lasting >4 months may indicate poor prog-
nosis. Continued long-term assessment of patients
recovering from WNV-associated paralysis is needed to
fully discern the spectrum of possible outcomes. 
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